SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Tallus Jussi)
 

Sökning: WFRF:(Tallus Jussi) > Human Serum Metabol...

  • Oresic, Matej,1967-Turku Centre for Biotechnology, University of Turku, Turku, Finland; Turku Centre for Biotechnology, Åbo Akademi University, Turku, Finland; Steno Diabetes Center A/S, Gentofte, Denmark; VTT Technical Research Centre of Finland, Espoo, Finland (författare)

Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain Injury

  • Artikel/kapitelEngelska2016

Förlag, utgivningsår, omfång ...

  • Elsevier,2016
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-53704
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-53704URI
  • https://doi.org/10.1016/j.ebiom.2016.07.015DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Traumatic brain injury (TBI) is a major cause of death and disability worldwide, especially in children and young adults. TBI is an example of a medical condition where there are still major lacks in diagnostics and outcome prediction. Here we apply comprehensive metabolic profiling of serum samples from TBI patients and controls in two independent cohorts. The discovery study included 144 TBI patients, with the samples taken at the time of hospitalization. The patients were diagnosed as severe (sTBI; n=22), moderate (moTBI; n=14) or mild TBI (mTBI; n=108) according to Glasgow Coma Scale. The control group (n=28) comprised of acute orthopedic non-brain injuries. The validation study included sTBI (n=23), moTBI (n=7), mTBI (n=37) patients and controls (n=27). We show that two medium-chain fatty acids (decanoic and octanoic acids) and sugar derivatives including 2,3-bisphosphoglyceric acid are strongly associated with severity of TBI, and most of them are also detected at high concentrations in brain microdialysates of TBI patients. Based on metabolite concentrations from TBI patients at the time of hospitalization, an algorithm was developed that accurately predicted the patient outcomes (AUC=0.84 in validation cohort). Addition of the metabolites to the established clinical model (CRASH), comprising clinical and computed tomography data, significantly improved prediction of patient outcomes. The identified 'TBI metabotype' in serum, that may be indicative of disrupted blood-brain barrier, of protective physiological response and altered metabolism due to head trauma, offers a new venue for the development of diagnostic and prognostic markers of broad spectrum of TBIs. (C) 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Posti, Jussi P.Division of Clinical Neurosciences, Department of Neurosurgery, Turku University Hospital, Turku, Finland; Division of Clinical Neurosciences, Department of Rehabilitation and Brain Trauma, Turku University Hospital, Turku, Finland; Department of Neurology, University of Turku, Turku, Finland (författare)
  • Kamstrup-Nielsen, Maja H.Steno Diabetes Center A/S, Gentofte, Denmark (författare)
  • Takala, Riikka S. K.Perioperative Services, Intensive Care Medicine and Pain Management, Turku University Hospital, Turku, Finland (författare)
  • Lingsma, Hester F.Department of Public Health, Erasmus MC-University Medical Center, Rotterdam, Netherlands (författare)
  • Mattila, IsmoSteno Diabetes Center A/S, Gentofte, Denmark; VTT Technical Research Centre of Finland, Espoo, Finland (författare)
  • Jäntti, SirkkuVTT Technical Research Centre of Finland, VTT, Espoo, Finland (författare)
  • Katila, Ari J.Perioperative Services, Intensive Care Medicine and Pain Management, Turku University Hospital, Turku, Finland (författare)
  • Carpenter, Keri L. H.Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom (författare)
  • Ala-Seppälä, HennaDivision of Clinical Neurosciences, Department of Rehabilitation and Brain Trauma, Turku University Hospital, Turku, Finland; Department of Neurology, University of Turku, Turku, Finland (författare)
  • Kyllönen, AnnaDivision of Clinical Neurosciences, Department of Rehabilitation and Brain Trauma, Turku University Hospital, Turku, Finland; Department of Neurology, University of Turku, Turku, Finland (författare)
  • Maanpää, Henna-RiikkaDivision of Clinical Neurosciences, Department of Rehabilitation and Brain Trauma, Turku University Hospital, Turku, Finland; Department of Neurology, University of Turku, Turku, Finland (författare)
  • Tallus, JussiDivision of Clinical Neurosciences, Department of Rehabilitation and Brain Trauma, Turku University Hospital, Turku, Finland; Department of Neurology, University of Turku, Turku, Finland (författare)
  • Coles, Jonathan P.Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom (författare)
  • Heino, IiroDivision of Clinical Neurosciences, Department of Rehabilitation and Brain Trauma, Turku University Hospital, Turku, Finland; Department of Neurology, University of Turku, Turku, Finland (författare)
  • Frantzén, JanekDivision of Clinical Neurosciences, Department of Neurosurgery, Turku University Hospital, Turku, Finland; Division of Clinical Neurosciences, Department of Rehabilitation and Brain Trauma, Turku University Hospital, Turku, Finland; Department of Neurology, University of Turku, Turku, Finland (författare)
  • Hutchinson, Peter J.Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom (författare)
  • Menon, David K.Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom (författare)
  • Tenovuo, OlliDivision of Clinical Neurosciences, Department of Rehabilitation and Brain Trauma, Turku University Hospital, Turku, Finland; Department of Neurology, University of Turku, Turku, Finland (författare)
  • Hyötyläinen, Tuulia,1971-Örebro universitet,Institutionen för naturvetenskap och teknik,Turku Centre for Biotechnology, University of Turku, Turku, Finland; Turku Centre for Biotechnology, Åbo Akademi University, Turku, Finland; Steno Diabetes Center A/S, Gentofte, Denmark; VTT Technical Research Centre of Finland, Espoo, Finland; Clinical Research Institute, Helsinki University Central Hospital, Helsinki, Finland; Department of Chemistry, Örebro University, Örebro, Sweden(Swepub:oru)tihn (författare)
  • Turku Centre for Biotechnology, University of Turku, Turku, Finland; Turku Centre for Biotechnology, Åbo Akademi University, Turku, Finland; Steno Diabetes Center A/S, Gentofte, Denmark; VTT Technical Research Centre of Finland, Espoo, FinlandDivision of Clinical Neurosciences, Department of Neurosurgery, Turku University Hospital, Turku, Finland; Division of Clinical Neurosciences, Department of Rehabilitation and Brain Trauma, Turku University Hospital, Turku, Finland; Department of Neurology, University of Turku, Turku, Finland (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:EBioMedicine: Elsevier12, s. 118-1262352-3964

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy